The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127856021 12785602 1 I 20160328 20160927 20160927 EXP US-PFIZER INC-3237001 PFIZER KONIARIS C., MCEWAN M., HANES M., BHATNAGAR N., GALICA R.. EPIDURAL CATHETER PLACEMENT FOR TREATMENT OF SICKLE CELL CRISIS IN A PARTURIENT. REG ANESTH PAIN MED. 2016;41(2) 30.00 YR F Y 0.00000 20160927 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127856021 12785602 1 PS BUPIVACAINE HYDROCHLORIDE/EPINEPHRINE BUPIVACAINE HYDROCHLORIDEEPINEPHRINE 1 10 ML, 0.125 %, LOADING DOSE Y UNK 16964 10 ML
127856021 12785602 2 SS BUPIVACAINE HYDROCHLORIDE/EPINEPHRINE BUPIVACAINE HYDROCHLORIDEEPINEPHRINE 1 Intravenous drip 14 ML, 0.044 %, FREQ: 1 HOUR ; INTERVAL: 1 Y UNK 16964 14 ML
127856021 12785602 3 SS FENTANYL CITRATE. FENTANYL CITRATE 1 Intravenous drip 14 ML, 1.25 MCG/ML, FREQ: 1 HOUR ; INTERVAL: 1 Y UNK 19115 14 ML
127856021 12785602 4 SS FENTANYL CITRATE. FENTANYL CITRATE 1 5 MCG/ML, LOADING DOSE Y UNK 19115
127856021 12785602 5 SS MORPHINE SULFATE. MORPHINE SULFATE 1 Intravenous (not otherwise specified) 2 MG, FREQ: 1 MINUTE; INTERVAL: 15 Y UNK 71849 2 MG SOLUTION FOR INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127856021 12785602 1 Pain
127856021 12785602 3 Pain
127856021 12785602 5 Pain

Outcome of event

Event ID CASEID OUTC COD
127856021 12785602 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127856021 12785602 Exposure during pregnancy
127856021 12785602 Hypoxia
127856021 12785602 Inadequate analgesia
127856021 12785602 Maternal exposure during pregnancy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found